1Gu M, Zhao G, Zhao K, et al. Novel Variants of Clade 2.3.4 Highly Pathogenic Avian Influenza A ( H5N 1 ) Viruses, China[J]. Emerg Infect Dis, 2013, 19 (12) : 2021-2024.
2Zhao K, Gu M, Zhong L, et al. Characterization of three HSN5 and one HSN8 highly pathogenic avian influenza viruses in China[J]. Vet Microbiol, 2013, 63 (3/4) .. 351-357.
3Zhong L, Zhao Q, Zhao K, et al. The antigenic drift mo- lecular basis of the HSN1 influenza viruses in a novel branch of clade 2.3.4[J] Vet Microbiol, 2014, 71 (1/2) .. 23-30.
4World Health Organization/World Organisation tbr Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5NI Evolution Working Group. Revised and updated no- menclature for highly pathogenic avian influenza A ( H5N 1 ) viruses[J]. Influenza Other Respir Viruses, 2014, 8 (3) : 384-388.
5Steel J, Burmakina S V, Thomas C, et al. A combina- tion in-ovo vaccine for avian influenza virus and Newcastle disease virus[J]. Vaccine, 2008, 26 (4) : 522-531.
6Hoffmann E, Stech J, Guan Y, et al. Universal primer set for the full-length amplification of all influenza A viruses[J]. Arch Virol, 2001, 146: 2275-2289.
7Kaverin N V, Rudneva I A, Govorkova E A, et al. Epit- ope mapping of the hemagglutinin molecule of a highly patho- genic H5N1 influenza virus by using monoclonal antibodies[J]. JVirol, 2007, 81: 12911-12917.
8Velkov T, Ong C, Baker M A, et al. The antigenic archi- tecture of the hemagglutiniq of influenza H5N1 viruses[J]. Mol Immunol, 2013, 56: 705-719.
